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SUMMARY
Fifty verocytotoxin (VT)-producing Escherichia coli (VTEC) strains of sero* 
group 0157 were characterized by phage typing, polymerase chain reaction (PCR)
4
for VT genes and the E. coli attaching and effacing (eae) gene, and random 
amplified polymorphic DNA-PCR (RAPD-PCR) fingerprinting. The collection 
represented isolates obtained from patients with diarrhoea-associated haemolytic- 
uraemic syndrome (D + HUS) and their family contacts, isolated in the 
Netherlands, Belgium and Germany between .1989 and 1993. Based on isolates 
from separate families (n = 27) seven different phage types were identified, types
2 (44%) and 4 (33%) were predominant. Eighty-five percent of the strains 
contained only VT2 gene sequences and 15 % both VT1 and VT2. All strains of the 
dominant phage types 2 and 4 carried the VT2 gene. Strains that belonged to the 
minor phage types 8, 14, 32 carried both VT1 and VT2 genes, with the exception 
of two isolates identified as phage types 49 and 54 which contained only VT2 
genes. All 0157 VTEC strains possessed the chromosomally-located eae gene, which 
indicates its usefulness as virulence marker. RAPD-PCR fingerprinting identified 
four distinct banding patterns, with one profile found among 79% of the strains. 
Based on the combined results of all typing methods used in this study, the 
collection of 50 0157 VTEC strains could be divided into nine distinct groups. 
Strains isolated from different persons within one family could not be distinguished 
by any of these methods. The data suggest that 0.157 VTEC strains are members 
of one clone that has become widely distributed.
INTRODUCTION
Verocytotoxin (VT)-ipvodnQmg Escherichia coli (VTEC) strains are implicated in 
the pathogenesis of the diarrhoea-associated form (D + ) of haemolytic-uraemic 
syndrome (HUS), which is the most common cause of acute renal failure in 
childhood [1]. Although VTEC strains that belong to serotypes 0157.H7 and 
0157 non-motile (0157. H“) are most frequently isolated from stools of patients 
with HUS, at least 50 other human VTEC serotypes are known [2]. The exact 
mechanisms of the attachment of VTEC to the human intestinal mucosa are not
well understood. However, based on in vitro and animal studies a model based on 
intimate adhesion with localized effacement of the microvilli and disruption of the 
cellular cytoskeleton at the site of attachment has been proposed. The intimate 
attachment may be mediated by the chromosomally encoded E. coli attaching and 
effacing (eae) gene product, an outer membrane protein [3]. Additional bacterial 
factors may contribute to the attachment and effacement phenotype of VTEC 
strains [4]. Accumulated evidence suggests that HUS may result from the 
systemic action of VT on vascular endothelial cells [1], VTEC strains produce two 
immunologically distinct VTs (VT1 and VT2), either singly or in combination. 
These are encoded by bacteriophages. Since these VTs are closely related to the 
Shiga toxin, they are often referred to as Shiga-like toxin (SLT-I and SLT-II) [5], 
In the past few years, variants of VT2 (VT2c or SLT-IIc) have been identified [6],
E. coli 015T.H7 has been isolated from cattle and foods of animal origin 
(contaminated meat, unpasteurized milk) [2], Waterborne and person-to-person 
transmission are also believed to be modes of spread of this pathogen [7-9]. 
Several phenotypic and genotypic schemes have been developed to assist in 
epidemiological investigations. These include typing of the strains by VT profile 
[6, 10-12], plasmid profile [10, 11, 13], restriction enzyme digestion and electro­
phoresis of plasmid [14] and whole cell DNA [15], multilocus enzyme electro­
phoresis [16, 17], phage type  [18-20] and antibiogram [9, 11]. In this study, 0157 
VTEC strains and 0111 VTEC strains were characterized which had been isolated 
from D + HUS-patients as well as from family contacts in three Western 
European countries. Besides phage type, the VTEC isolates were examined for 
toxin profile and the presence of the eae gene by a multiplex polymerase chain 
reaction (PCR). To determine the genetic relationship of the strains PCR-based 
fingerprinting was used.
METHODS
Clinical VTEC isolates
Fifty-two human faecal VTEC isolates were studied, including 30 isolates from
19 children with D + HUS, nine isolates from family contacts (n = 9) of five of 
these HUS-patients, 11 isolates from family contacts (n = 11) of seven patients 
with D + HUS from which no VTEC had been isolated, one isolate from an adult 
with D + HUS, and one isolate from a child with acute, bloody gastroenteritis. 
The isolates obtained from patients from the Netherlands, Belgium and Germany 
were collected between 1989 and 1993. Forty-six strains had been characterized as 
serotype 0157.H7, four as serotype 0157.H" and two as serotype 0111.H~. As 
controls, 6 VT-negative E. coli 0157 isolates from raw retail meats bought in the 
Netherlands and 8 both VT-positive and VT-negative E. coli strains belonging to 
serogroups 0157 (n = 3), 0111 (n =  3) and 026 (n = 2) obtained from Dr M. A. 
Karmali (Hospital for Sick Children, Toronto, Canada) and from Dr W. Jansen 
(National Institute of Public Health and Environmental Protection, Bilthoven, 
the Netherlands) were included. In contrast to the VT-positive E, coli 0157 
isolates, the VT-negative E , coli 0157 strains were able to ferment sorbitol and 
possessed the enzyme yî-glucuronidase. The bacterial cells were stored at -7 0  °C 
in glycerol-containing (10%) medium.
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Table 1. Oligonucleotide primers used for the detection of verocytotoxin (VT) and
Escherichia coli attaching and effacing (eae) gene sequences
Size of
PCR
product
Primer Nucleotide sequence Location* (bp)
VT1-1 5'-GGCAGATGGAAGAGTCCGTGGGATTACGC-3' 1011--1039 179
VT1-2 Ö '-C AC AATC AG G C G TC G C C AG C G C AC TTG C TS' 1101--1189
VT2-1 5'-CCACATCGGTGTCTGTTATTAACCACACC-3' 408--436 372
VT2-2 5'-GCAGAACTGCTCTGGATGCATCTCTGGTC-3' 751--779
eae-1 5'-TGCGGCACAACAGGCGGCGA-3't 2078-“2097 629
eae-2 ö'-CGGTCGCCGCACCAGGATTC-3' 2687--2706
* The position numbers are those in the published nucleotide sequences of VT1 [22], VT2 [23] 
and eae [24],
Phage typing
Phage typing of the 50 0157 VTEC isolates was performed by Dr B. Rowe 
(Laboratory of Enteric Pathogens, Central Public Health Laboratory, London, 
United Kingdom).
DNA preparation
Bacteria were grown in Tryptic Soy Broth at 37 °C, overnight. Genomic DNA 
was isolated as follows : 1 ml of an overnight culture was centrifuged in a 
mi ero centrifuge, and the cells were resuspended in 250 /¿I STET buffer (233 m i  
sucrose, 50 mM-TRIS-HCl (pH 8*0), 20 mM-EDTA, 5% Triton X-100). Lysozyme 
was added to a final concentration of 1*7 mg/ml. The suspension was incubated at 
room temperature for 5 min, then heated at 100 °C for 1 min and put on ice for 
another 2 min. In succession, sodium dodecyl sulphate and proteinase K were 
added to a final concentration of 0*3% and 0*5 mg/ml, respectively. Then, the 
solution was incubated at 55 °C for 2 h. Following extraction with phenol, 
0*03 mg/ml RNAse A was added and the mixture was incubated at 37 °C for
20 min. The solution was extracted successively with phenol/chloroform/ 
isoamylalcohol (25:24:1) and chloroform/isoamylalcohol (24:1). The DNA was 
precipitated overnight and resuspended in 100 ¡A of distilled water [21]. An aliquot 
was electrophoresed in an agarose gel (1 %) containing 0*1 /¿g/ml ethidium 
bromide to estimate the DNA yield and verify DNA integrity.
Polymerase chain reaction
The VTEC strains were examined for the presence of VT and eae gene sequences 
by performing a hot start multiplex PCR. Table 1 shows the sequences of the 
oligonucleotides. The oligonucleotide primer pairs targeted conserved sequences 
found in the genes encoding VT1, VT2 and types or variants of the VT2 family, 
and the eae gene product. PCR reaction mixtures (50 /¿l) contained 75 mM-TRIS- 
HC1 (pH 9*0), 2*5 mM-MgCl2, 20 mM-(NH4)2S04, 0*01 % Tween-20, 0-2 mM-dNTPs 
each, 0*2 U of Taq DNA polymerase (Thermoperfectplus DNA polymerase, 
Integro, Zaandam, the Netherlands) and 20 pmol of the primers VT1-1, VT1-2, 
VT2-1, VT2-2, eae-1, eae-2 each. The amount of template DNA used was 
approximately 5 ng per reaction. Negative (no template DNA) and positive (5 ng
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Table 2. Primers used for polymerase chain reaction fingerprinting of
verocytotoxin-producing Escherichia coli
Primer Nucleotide sequence
Percent
G +  C (Reference)
1247 5'-AAQAGCCCGT--3/ 60 [25]
1254 5'-CCGCAGCCAA-3' 70 [25]
1281 ö'-AACGCGCAAC-3' 60 [25]
1283 5'-GCGATCCCCA-3' 70 [25]
1290 5'-GTGGATGCGA-3' 60 [25]
RPl-4 5'-TAGGATCAGA-3' 40 [26]
RP2 ö'-AAGGATCAGA-ä' 40 [26]
Soy ö'-AGGTCACTGA-3' 50 [27]
HLWL85 5 ' - A C A ACTG CTC - 3 ' 50 [28]
HLWL74 5'-ACGTATCTGC-3' 40 [28]
D8635 5'-GAGCGGCCAAAGGGAGCAGAC-3' 67 [25]
ERIC1R 5'-ATGTAAGCTCCTGGGGATTCAC-3' 50 [29]
ERIC2 5'-AAGTAAGTGACTGGGGTGAGCG-3' 55 [29]
of purified genomic DNA from VTEC 0157. H7 reference strain EDL931 ) controls 
were included in each experiment. Amplification was performed in a DNA thermal 
cycler (Perkin-Elmer Cet us). The thermal profile involved an initial dénaturation 
at 94 °C for 5 min followed by 40 cycles of dénaturation at 94 °C for 1 min, primer 
annealing at 59 °C for 3 min, and primer extension at 72 °C for 3 min. The final 
step was a 10 min incubation at 72 °C. After amplification, 15 /A aliquots were 
analysed by electrophoresis in 1*5% agarose gels containing ethidium bromide 
(O'l /¿g/ml), visualized by UV transillumination and photographed. Molecular 
mass markers (100 bp ladder; Pharmacia, Roosendaal, the Netherlands) were 
electrophoresed simultaneously.
PCR fingerprinting
PCR fingerprinting of bacterial DNA (50 ng) was performed in a 50 ¡A reaction 
volume containing 75 mM-TRIS-HCl (pH 9*0), 2*5 mM~MgCl2, 20 mM-(NH4)2S04, 
0*01 % Tween-20, 0*2 mn-dNTPs each, 50 pmol of primer (see Table 2 for the 
primer sequences) and 0*2 U of Taq DNA polymerase (Thermoperfectplus DNA 
polymerase, Integro, Zaandam, the Netherlands). A negative control, consisting 
of the same reaction mixture but with no template DNA added, was included in 
each reaction. A Perkin-Elmer thermal cycler was used for amplification running 
either of three programmes. The cycling programme when using 10-nucleotide 
primers was four cycles of 94 °C for 5 min, 36 °C for 5 min, 72 °C for 5 min, 30 
cycles of 94 °C for 1 min, 36 °C for 1 min, 72 °C for 2 min, and then 72 °C for 10 min 
[25]. The cycling programme when using primer D8635 was four cycles of 94 °C for 
5 min, 40 °C for 5 min, 72 °C for 5 min (low stringency amplification), 30 cycles of 
94 °C for 1 min, 55 °C for 1 min, 72 °C for 2 min (high stringency amplification), 
and final incubation at 72 °C for 10 min [25]. The primers ERIC1R and ERIC2 
required a programme consisting of 35 cycles of 94 °C for 1 min, 25 °C for 1 min, 
74 °C for 2 min, preceded by a 5-min incubation at 94 °C and followed by a final 
extension step at 74 °C for 10 min [30], Amplified DNA (5 /¿I) was separated by gel 
electrophoresis in 1*5 % agarose gels and visualized by ethidium bromide staining 
(0*1 /¿g/ml). A molecular size marker (100 bp ladder; Pharmacia, Roosendaal, the
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Table 3. Characterization of the human faecal VTEC strains by serotype, verocytotoxin 
(VT) genotype, Escherichia coli attaching and effacing (eae) gene, random amplified 
polymorphic DNA-polymerase chain reaction (RAPD-PCR) and phage type
Results for J
Family Strain t______ a______  ^ RAPD Phage Overall
no. no.* Serotype Sourcef VT1 VT2 eae profile§ type I typelf
I 1 0157 .H7 HUS-patient — + 4* A 4 1
II 2a 0157. H7 HUS-patient — + + B 4 2
2b 01 5 7 .H7 HUS-patient — + + B 4 2
III 3a O l i i .  H- HUS-patient — — C ND
3b 0111. Hr HUS-patient — + ,— C ND
IV 4 0157. H7 Family contact — + + B 2 3
V 5 0157. H7 Family contact + + + B 32 4
6 0157. H7 Family contact + + B 32 4
VI 7 0157. H7 HUS-patient — + A 4 1
8 0157. H7 Family contact — 4- + A 4 1
9 0157. H7 Family contact — + A 4 1
VII 10 0157. H7 Family contact — H" + B 2 3
VIII 11a 0157. H7 HUS-patient + B 2 3
l ib 0157. H7 HUS-patient ,— H" B 2 3
11c 0157, H7 HUS-patient — + B 2 3
12 0157. H7 Family contact — + + B 2 3
13 0 1 5 7 .H7 Family contact — + + B 2 3
14 0157. H7 Family contact — + B 2 3
IX 15 0157.H 7 Family contact — + + B 4 2
16 0157. H7 Family contact — + + B 4 2
X 17 0 1 5 7 .H7 Family contact + + B 14 5
XI 18 0157. H" Family contact — liihj lU + B 4 2
19 0157. H- Family contact — + + B 4 2
X II 20 0157. H7 Family contact ,— B 4 2
21 0157. H7 Family contact -------- + + B 4 2
X III 22 0157. H7 HUS-patient — w | m *4 j* " B 2 3
XIV 23 0157. H7 HUS-patient — + B 2 3
XV 24 01 5 7 .H7 HUS-patient — + + B 2 3
Netherlands) was used for reference. Gels were photographed and interpretation 
of banding patterns was performed by visual inspection.
Phage typing
Among the 50 VTEC isolates of serogroup 0157, seven phage types were 
identified (Table 3). Sequentially isolated 0157 VTEC strains from one patient 
(Table 3, no. 2a-2b, l la - l lc ,  27a-27g, 36a-36b) appeared to belong to the same 
phage type. The same was true for strains which had been isolated from different 
persons within one family. Based on E. coli 0157 isolates from separate families 
phage type 2 was the most common (44% of the strains), followed by types 4 
(33%), 8 (7%), 14 (4%), 32 (4%), 49 (4%), and 54 (4%).
Amplification of toxin and eae gene sequences
Figure 1 shows the DNA products generated by PCR amplification using the 
primers VT1-1, VT1-2, VT2-1, VT2-2, eae-1 and eae-2 in a multiplex PCR assay
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Table 3 (cont.)
Results for J
Family
no.
Strain
no.* Serotype Sourcef VT1
A
VT2
.......
eae
RAPD Phage Overal 
profile§ type H type^f
XVI 25 0 1 5 7 .H “ HUS-patient (adult) + + + B' 8 6
XVII 26 0 1 5 7 .H7 HUS-patient — + + B 2 3
XVIII 27 a 0157. H7 HUS-patient — + + B" 49 7
27 b 0157, H7 HUS-patient — + + B" 49 7
27 c 0157. H7 HUS-patient — + B" 49 7
27 d 0157. H7 HUS-patient — t. |..i B" 49 7
27e 0157. H7 HUS-patient — ■«»I * *i j i» B" 49 7
27f 0157. H7 HUS-patient — + B" 49 7
27g 0157. H7 HUS-patient — + B" 49 7
28 0157.H 7 Family contact — B" 49 7
XIX 29 0157.H 7 HUS-patient — + + B 4 2
XX 30 0157.H 7 HUS-patient — + + B 2 3
31 0 1 5 7 . H7 Family contact -— -h + B 2 3
32 0157 .H7 Family contact — Jr + B 2 3
X X I 33 0157.H 7 HUS-patient — + + B 2 3
34 0157. H7 Family contact — 4* B 2 3
X X II 35 0 1 5 7 .H7 HUS-patient (BEL) — + + B" 2 8
X X III 36a 0157 .H 7 HUS-patient (BEL) — + + B 2 3
36b 0 1 5 7 .H7 HUS-patient (BEL) — -f + B 2 3
XXIV 37 0157.H 7 HUS-patient (BEL) — 4- B 2 3
XXV 38 0157 >H7 HUS-patient (BEL) — + + B 4 2
XXVI 39 0157. H7 HUS-patient (GER) — + H" B 4 2
XXVII 40 0157. H7 HUS-patient (GER) — + B 54 9
XXVIII 41 0157. H “ Gastroenteritis-patient + « | m B' 8 6
* a-g represent sequentially isolated strains from the same person.
Ï' (BEL), patient from Belgium; (GER), patient from Germany.
j  + , positive ; —, negative.
§ B '-B '"  represent similar, but slightly different DNA patterns.
II ND, not done.
íf Based on VT genotype, RAPD-PCR jjrofile and phage type.
on several strains. Amplification products were generated from positive control 
strains, including a 179 bp fragment for VTl-positive strains (Table 4, no. 8, 10, 
11, 13,14), a 372 bp fragment for VT2-positive strains (Table 4, no. 7, 8, 10) and 
a 629 bp fragment for eae-positive strains (Table 4, no. 7, 8, 10-14). The E . coli 
O lii  control strain no. 10 previously identified by neutralization assays as a 
VT2~producer, also appeared to contain VT1 gene sequences. No amplification 
occurred when PCR was performed with negative controls (Table 4, no. 1-6, 9), Of 
the 50 human 0157 VTEC isolates characterized in this study, 45 were positive for 
the VT2 gene only and five were positive for both VT1 and VT2 genes (Table 3), 
Sequentially isolated 0157 VTEC strains from the same patient (Table 3, no, 
2a-2b, l la - l lc ,  27a-27g, 36a-36b), and VTEC strains which had been isolated 
from different persons within one family showed the same toxin profile. Based on 
isolates from separate families, 21 of the 23 VT2-positive E. coli 0157 isolates were 
characterized by the predominant phage types 2 and 4. The two remaining VT2- 
positive 0157 VTEC strains (Table 3, no. 27a-28, 40) and the four 0157 VTEC 
positive for both VT1 and VT2 were characterized by the less frequently 
encountered phage types 8, 14, 32,49 and 54. All 50 0157 VTEC strains contained
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M a b d f g 17 25 41 1 12 3a
bp
629
372
179
Fig, 1. Determination of VT and eae genes by PCR. The specific E . coli strains are 
indicated on top. a, enteropathogenic E, coli (O li i  ,B4; eae) ; b, JB28 (VTí) ; c, CL15A 
(0113.H21 ; VT2c); d, CL13A (0146.H"; VT1, eae); e, E32511 (0157.E~; VT2c, eae); 
f, isolate from raw meat (022.K " ; VT1, VT2), g, EDL931 (0157.H7 ; VT1 + , VT2 + , 
eaeH- ). See Table 3 for details of strains no. 5~3a. VTl-positive amplification resulted 
in a 179 bp fragment, VT2 in a 372 bp fragment and eae in a 629 bp fragment. M  — size 
marker (100 bp ladder).
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Table 4. Characterization of the E. coli control strains by serotype, verocytotoxin (VT), 
production, VT genotype, E. coli attaching and effacing (eae) gene and random 
amplified polymorphic DNA-polymerase chain reaction (RAPD-PCR)
Strain no. PCR results* for
(Source or reference
no.) Serotype
Production
of VT ' VT1
A
VT2
...............................Ï
eae
RAPD
profile
1 (chicken heart) 0157Í — — — — F
2 (chicken meat) 0157J — — — — G
3 (chicken wings) 0157J — — — — G
4 (sausage) 0157t — — — — H
5 (raw chicken fillet) 0157Î — — — — H
6 (raw turkey) 0157Ì — — — — I
7 (E32511) 0157. H- VT2c — + + B"'
8 (EDL931) 0157. H7 VT1 +  VT2 + + +
9 ( - ) 0157Î ------- — — — J
10 (H30C5) O l i i .  H- VT2 + + + K
11 (CL37A1) 0111. H8 VT1 + — + K
12 [EPEC]f 0111.B4 — — — + L
13 (CL19) 0 2 6 .H U VT1 + — + M
14 (H19) 026.H11 VT1 — + N
* + , positive; —, negative, 
f  EPEC, enteropathogenic E . coli.
I  Sorbitol- and /7-glucuronidase positive.
th e  eae gene sequences. The two O lii . H- strains (Table 3, no. 3a, 3b) were only 
positive for the VT2 gene. Negative PCR results were obtained for VT1 and eae 
gene sequences.
-PCR fingerprinting
PCR fingerprinting was initially performed with the 13 different primers (Table 
2) on a random selection of 10 E. coli 0157 strains in a pilot experiment. The
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M 1 2a 2b 3a * 3b 4 ** 5 6 7 8 9 10 i l a l l b l l c I 2  13 14 M
A B B C D C B E B B  A A A  B B B B B B B
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bp
1000
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340
B B B B  B B ' B B B B B B B '
Fig. 2, Random amplified polymorphic DNA-polymerase chain reaction of human 
faecal verocytotoxin-producing E .  coli .  Numbers indicate the isolates and letters are 
RAPD-PCR profiles, as described in Table 3. Strains isolated from the same family are 
underlined. M  =  size marker (100 bp ladder). *, Serratia  marcescens\ ** E . coli 0 2 .K".
primers were used either as a single or a pairwise combination. Primer 1247 gave 
the highest resolution and was therefore used for all strains listed in Tables 3 and 
4. Each DNA preparation was tested in duplicate to ascertain the reproducibility 
of the PCR. Figures 2 and 3 show the random amplified polymorphic DNA-PCR 
(RAPD-PCR) profiles obtained for the 52 VTEC isolates and the 14 controls, 
respectively. Banding patterns were coded by letters A-N, also reported in Tables
3 and 4. Genotypic codes B-Bw represented similar but slightly different DNA 
banding patterns. Profile B shared four bands with the banding patterns referred
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1 2 3 4 5 6
bp
1000 —
680 —
340 —
F G G H H I 
M  7 8 9 10 11 12 13 14
bp
1000 —
680 —
340 —
B" B#' J K K L M N
Fig. 3. Random amplified polymorphic DNA-polymerase chain reaction of the E . coli 
control strains. Numbers indicate the isolates and letters are R A PD -PC R  profiles, as 
described in Table 4. Isolates of the same serotype are underlined. M  =  size marker 
(100 bp ladder).
to as B', B" and B"' : one major band at 1000 bp, a minor band at 680 bp and two 
minor bands near 340 bp* Profile B' was characterized by a major band at 1200 bp. 
Whereas profiles B and B' showed two minor bands in between 800 and 900 bp, 
profiles B" and B'" did not. Profile B" was further characterized by one major 
band at 830 bp, and profile B"' by the absence of a minor band near 600 bp. Figure 
3 demonstrates that strains of different serotypes generated clearly distinct 
fingerprints. Furthermore, within a single serogroup different genotypes were 
encountered. Among the nine i?, coli 0157 isolates presented in Table 4, six distinct 
fingerprints were identified : the two VTEC strains no. 7 and no. 8 shared the same 
banding pattern, whereas for the seven VT-negative 0157 strains five different 
patterns were obtained. The VT-negative isolate no. 12 stood apart from the VTEC 
isolates no. 10 and no. 11 (Table 4), though all three isolates belonged to serogroup 
O lll. Although VTEC isolates no. 13 and 14 (Table 4) both belonged to serogroup 
026, each produced distinct RAPD-PCR profiles. DNA fingerprints of the 0157 
VTEC strains isolated from the HUS-patients, from their relatives and from the 
patient with bloody enteritis showed highly monomorphic patterns (Fig. 2). Based 
on the fingerprint patterns, the collection of 50 isolates could be divided into four 
different groups: A, B, B' and B". Sequentially isolated 0157 VTEC strains from 
one patient (Table 3, no, 2a-2b, l la - l lc ,  27a-27g> 36a-36b), as well as strains
. i
' y,
' ; \  I '<\v: ' -
i ' ’ '
' '> '  
r  I , • •  s s  ,
s ; .
' m m ' -
' íiVoV/*:*:’•ti
•*. - i - ,r :
; jV.t'/s r/v
which had been isolated from different persons within one family showed the same 
banding patterns. Based on isolates from separate families, fingerprint profile B 
was observed for 21 of the 27 0157 VTEC isolates (79%), followed by profiles 
B" and A each for two (7%) of the strains. The B, B' and B" profiles were very 
similar to the B'" profile produced by the 0157 VTEC reference strains (Table 4, 
no. 7, 8). Some strains which were different by phage typing and VT genotyping 
could not be discriminated by RAPD-PCR fingerprinting, for example strains no.
4 and no. 17 (Table 3). However, some strains discriminated by RAPD-PCR 
fingerprinting could not be discriminated by phage typing nor by VT genotyping, 
for example strains no. 1 and no. 29 (Table 3). Combining the results of all typing 
methods used, the collection of 50 0157 VTEC strains could be divided into nine 
distinct groups (see the right part of Table 3). I t has to be remembered that these 
50 strains were isolated from 27 families. The two 0111 VTEC strains (Table 3, no. 
3a, 3b) showed a unique banding pattern, encoded by the letter C.
DISCUSSION
The predominant phage types identified among the 0157 VTEC isolates 
characterized in this study correspond with the observation by Frost and co­
workers [19]. Among a total of 1092 0157 VTEC strains isolated in the UK 
between 1989 and 1991, they identified types 2 (36-1%), 49 (29*6%), 1 (10*3%) 
and 4 (8*9%) the most frequently. Frost and colleagues [19] also observed that 
strains of phage types 2 and 49 carried only VT2 genes. It is remarkable that, 
unlike phage types 2 and 4, 0157 VTEC phage type 49 has not been reported from 
North America [20].
The 0157 VTEC isolates were also tested for their cytotoxicity by using the 
vero-ceil assay (unpublished observations). Culture filtrates of all strains were 
neutralized by antibodies to VT2 only. PCR revealed that five of the 0157 VTEC 
isolates contained VTl gene sequences in addition to VT2 gene sequences. A 
possible explanation for the failure to detect VTl in neutralization assays while 
PCR yielded positive results for the VTl gene, might be that the VTl gene does 
not become expressed. On the other hand, it has been observed that when both 
toxins are produced by the same strain, VTl predominates in cell lysates and VT2 
was the more active toxin in supernates [5]. Therefore, it might be possible that 
VTl titres in culture supernates were too low to be detected in neutralization 
assays. The higher prevalence of infection among HUS-patients with VTEC 
producing only VT2 than infection with VTEC producing either only VTl or a 
combination of VTl and VT2, is consistent with other studies carried out in 
Western Europe and North-America [2, 31]. However, Rowe and co-workers [32] 
recently found that 22 of the 26 0157.H7 VTEC isolates from Canadian HUS- 
patients produced both VTl and VT2 rather than VT2 only.
All 0157 VTEC strains contained eae-specific DNA sequences. The presence of 
the eae gene has been closely associated with 0157 VTEC that caused HUS and 
is assumed to be a virulence marker [33-36]. Our results strongly support this 
suggestion. Since spontaneous loss of VT genes during cultivation of human E , coli 
strains has been documented [37], the eae gene is possibly an even more reliable 
marker than the VT genes. The eae gene is responsible for intimate attachment to
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and effacement of the intestinal epithelial cell microvilli, leading to damage of the 
epithelium [3]. This would allow the passage of bacterial products which are 
normally excluded from the circulation. I t is not yet clear why the family 
members of the HUS-patients did not develop HUS, although they had been 
colonized with VTEC strains positive for the eae gene. The tw oE . coli O l i i  strains 
appeared to be negative for the eae gene. I t  is known that the eae gene is not 
always present in VTEC of serogroups other than 0157 [38]. The possibility exists 
that the HUS-patient, from who the E . coli 0111 strains had been isolated, was 
simultaneously infected with a second VTEC positive for the eae gene. Co-infection 
with two different serotypes of VTEC has been reported before [31, 39, 40].
Since E . coli 0157.H7 and E, coli 0157.H” are increasingly implicated in 
human diseases, a single and reliable method to compare these strains is needed. 
A good epidemiological typing scheme could assist in elucidating the route of 
transmission of these pathogens. Recently, PCR-based fingerprinting has been 
successfully used to study relatedness among epidemic isolates of various species 
as reviewed by Van Belkum [41]. This typing method uses a single or a pairwise 
combination of primers to amplify target genomic DNA by PCR, resulting in 
specific arrays of DNA products. Recently, Wang and co-workers applied 
RAPD-PCR to a limited number of 0157 VTEC strains using five different 
arbitrary primers [42]. In contrast to Wang and colleagues we did not find the 
highest resolution with primer 1290, but with primer 1247, Although the isolates 
were obtained from different cases of HUS during a prospective study and no 
contact between the infected persons except for family contacts were present, 
genetic homogeneity in the 0157 VTEC isolates was observed by RAPD-PCR 
fingerprinting. The collection of 50 0157 VTEC rendered only four different 
fingerprint patterns. Fingerprint profile B was obtained for 35 of the isolates. I t  
was considered very similar to the patterns produced by the 0157 VTEC reference 
strains E32511 and EDL931, which had been isolated in Britain and the USA 
respectively. The minor variations between the B, B', B" and B'" patterns might 
be due to different sites of integration of phages into the bacterial chromosome. As 
group, fingerprint profiles B-B'" were obtained for 27 (93 %) of the 29 0  157 VTEC
strains tested (based on independent isolates ; including the two reference strains 
E32511 and EDL931). It has to be emphasized that the primer with the highest 
resolution was used. Some 0157 VTEC isolates produced a clearly different 
banding pattern, referred to as A. These findings suggest that the isolates were 
distinct from the strains producing profiles B-B'", because it is highly unlikely 
that such different patterns have arisen by phage integration at a different site. 
The homogeneous DNA fingerprints observed in the present study for VTEC of 
serotypes 0157. H7 and 0157. H“ correspond with previously reported studies on 
analysis of chromosomal DNA of these pathogens using multilocus enzyme 
electrophoresis and pulsed-field gel electrophoresis [15-17, 43]. A recent clonal 
expansion from a common progenitor strain has been suggested [17]. However, 
some authors have reported that epidemiologically independent 0157 VTEC 
strains could be differentiated using pulsed-field gel electrophoresis or restriction 
fragment length polymorphism (RFLP) [44-46].
Based on the combined results of phage typing, VT genotyping and RAPD-PCR 
fingerprinting, the collection of 50 0157 VTEC strains (isolated from 27 families)
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could be divided into nine distinct groups. Considering the phage typing and 
RAPD-PCR results of the present study and published data on typing of 0157 
VTEC, it seems likely that VTEC of serotypes 0157.H7 and 0157. H~ are
members of a single clone tha t has become widely distributed. Although the 
genomic DNA appears to be highly conserved, minor variations may occur by the 
integration of phages into the bacterial chromosome.
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